Today: 16 April 2026
MP Materials stock pops as William Blair starts coverage and rare-earth price floors hit the agenda again
14 January 2026
1 min read

MP Materials stock pops as William Blair starts coverage and rare-earth price floors hit the agenda again

New York, January 14, 2026, 14:36 EST — Regular session

  • Shares of MP Materials jumped roughly 7.5% by mid-afternoon, bouncing between $62.20 and $68.73 earlier in the session
  • A day earlier, William Blair kicked off coverage, highlighting MP’s U.S. “mine-to-magnet” footprint
  • Investors digested new G7 talks on setting rare-earth price floors and related supply strategies

Shares of MP Materials climbed roughly 7.5% Wednesday, closing at $68.63. The rare-earths miner dipped as low as $62.20 earlier in a volatile session before bouncing back.

Wall Street is zeroing in on rare-earth supply chains, where policy and pricing weigh heavily alongside production. On Tuesday, William Blair analyst Neal Dingmann kicked off coverage, dubbing MP “the only fully integrated U.S. mine-to-magnet producer.” He highlighted that MP’s U.S. presence is gaining value as governments prioritize non-China sources. William Blair

This week in Washington, the policy focus intensified. Finance ministers from the G7 discussed setting price floors for rare earths — essentially a minimum price to shield producers outside China if market prices fall too low. Germany’s finance minister Lars Klingbeil noted the benefit: “the market then knows what prices it can expect,” though he added that the specifics still need ironing out. Reuters

Australia, a major supplier to Western manufacturers, announced this week it will focus on rare earths within a A$1.2 billion critical minerals reserve. The move aims to bolster supply chains and provide allies with supply rights and offtake-style deals.

For MP, price floors are very real. A July 2025 securities filing revealed a Department of Defense partnership involving a $400 million equity injection and a 10-year NdPr price floor fixed at $110 per kilogram. This deal also includes longer-term offtake agreements connected to magnet production.

NdPr stands for neodymium-praseodymium, two rare earth elements essential for permanent magnets that turn power into motion in everything from electric motors to defense gear. A “price floor” acts as a safety net: if the market price dips below that level, the buyer compensates for the shortfall.

Investors are also eyeing Apple’s evolving customer lineup as the company moves into higher-value products. In 2025, Apple inked a $500 million deal for rare-earth magnets with MP, marking a rare direct supply-chain bet by a major tech player aiming to cut reliance on China-based sources.

That said, the trade faces risks. MP’s next move hinges on expanding downstream capacity and meeting deadlines. Prices for rare earths could stay unstable if Chinese output grows or demand slips. Plus, government price support often carries conditions — and political risks — if policy shifts.

Investors are now focused on execution and any new policy cues. The next big date is MP’s earnings report, set for Feb. 19 after the market closes.

Stock Market Today

  • Amerigo Resources Q1 2026 Results Signal Capital Allocation Shift with Dividend and Buyback
    April 15, 2026, 9:21 PM EDT. Amerigo Resources Ltd. (TSX:ARG) reported Q1 2026 operating results reaffirming full-year copper and molybdenum production guidance. The company completed a C$5.9 million share buyback and declared a C$0.16 per-share performance dividend payable in May 2026. Despite scheduled maintenance, cash costs trended below guidance, highlighting operational efficiency. Amerigo's single-asset strategy focuses on cash generation and capital returns, underscored by this combination of buyback and special dividend. Shares have risen but appear undervalued by roughly 30% against fair value estimates ranging from C$5.26 to C$9.15. However, recent insider selling adds risk. The firm's capital discipline and market positioning suggest investors watch copper prices, MVC execution, and future capital decisions closely.

Latest article

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

Norse Atlantic Cancels All LAX Summer Flights as Fuel Costs Force Los Angeles Retreat

16 April 2026
Norse Atlantic Airways has canceled all planned summer flights from Los Angeles to London Gatwick, Paris, and Rome, citing surging jet fuel costs. The airline launched a $110 million rights issue, secured a $70 million bridge loan, and withdrew its 2026 outlook. Routes disappeared from booking systems on April 14. Norse had been the only scheduled operator on the Gatwick-Los Angeles route.
S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

S&P 500 Hits Record High as Iran Deal Hopes, Bank Earnings Lift Wall Street

16 April 2026
The S&P 500 closed at a record 7,022.95 and the Nasdaq at 24,016.02 on Wednesday, erasing losses from the March selloff tied to the Feb. 28 conflict. Bank of America reported $8.6 billion in first-quarter net income, up 17%, while Morgan Stanley posted record revenue. Talks between Washington and Tehran raised hopes for easing oil supply fears, but Brent crude stayed elevated at $94.93 a barrel.
Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

Tesla’s U.S. Solar Bet Faces China Export Threat as Energy Arm Becomes More Profitable Than Cars

16 April 2026
China is considering export restrictions on advanced solar-manufacturing equipment to the U.S., potentially affecting Tesla’s plans for new factories, sources told Reuters. Tesla aims to buy $2.9 billion in solar-panel equipment from China and expand U.S. solar production. China produces over 80% of global solar panel components. No final decision has been made, and consultations remain preliminary.
Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

Hims & Hers Stock Surges as FDA Reopens Peptide Rules, Shifting Focus Beyond GLP-1 Drama

15 April 2026
Hims & Hers Health shares rose 14% to $24.29 after the FDA said it will review restrictions on several peptides, including BPC-157 and TB-500. The agency set a July advisory meeting and will remove some peptides from its safety-risk list within a week. Hims, which acquired a California peptide facility last year, reported $2.35 billion in 2025 revenue and 2.511 million subscribers.
Constellation Software stock tumbles to new 52-week low as investors question acquisition-led growth
Previous Story

Constellation Software stock tumbles to new 52-week low as investors question acquisition-led growth

Sasol stock jumps 6% as oil climbs and South Africa tariff talks heat up
Next Story

Sasol stock jumps 6% as oil climbs and South Africa tariff talks heat up

Go toTop